Pacific Biosciences Of California (PACB) Times Interest Earned (2011 - 2026)
Pacific Biosciences Of California's (PACB) quarterly Times Interest Earned came in at -$4.8 in Q1 2026, up 98.03% year-on-year from -$2.43 in Q1 2025, and up 74.35% quarter-over-quarter from -$18.73 in Q4 2025.
Pacific Biosciences Of California (PACB) Times Interest Earned (2011 - 2026) Analysis & Trends
Pacific Biosciences Of California's Times Interest Earned history runs 16 years deep, the most recent figure standing at -$4.8 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 98.03% year-over-year to -$4.8 in Q1 2026; TTM through Mar 2026 was -$17.93, a 75.02% increase from a year earlier, with the FY2025 full-year figure at -$0.82, up 3.9% from the prior year.
- Times Interest Earned rose to -$4.8 in Q1 2026 per PACB's latest filing, from -$18.73 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$2.34 in Q3 2024 and bottomed at -$244.41 in Q1 2025.
- The 5-year median for Times Interest Earned is -$18.73 (2025), against an average of -$35.8.
- Across the five-year window, Times Interest Earned slumped 8134.41% in 2025 and surged 98.03% in 2026, its largest moves.
- Year by year, Times Interest Earned stood at -$35.43 in 2022, then jumped by 49.72% to -$17.81 in 2023, then plunged by 646.4% to -$132.95 in 2024, then jumped by 85.92% to -$18.73 in 2025, then jumped by 74.35% to -$4.8 in 2026.
- Per Business Quant, the three latest PACB Times Interest Earned figures stand at -$4.8 (Q1 2026), -$18.73 (Q4 2025), and -$22.36 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.90 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 13.19 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.15 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.19 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 82.35 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -2.90 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 5.36 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Pacific Biosciences Of California | 428.15 Mn | 152.18 Mn | 12.84 Mn | -4.80 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.80 |
| Dec 31, 2025 | -18.73 |
| Sep 30, 2025 | -22.36 |
| Jun 30, 2025 | -25.54 |
| Mar 31, 2025 | -244.41 |
| Dec 31, 2024 | -132.95 |
| Sep 30, 2024 | -2.34 |
| Jun 30, 2024 | -6.41 |
| Mar 31, 2024 | -2.97 |
| Dec 31, 2023 | -17.81 |
| Sep 30, 2023 | -3.01 |
| Jun 30, 2023 | -20.59 |
| Mar 31, 2023 | -25.14 |
| Dec 31, 2022 | -35.43 |
| Sep 30, 2022 | -6.76 |
| Jun 30, 2022 | -18.46 |
| Mar 31, 2022 | -20.97 |
| Dec 31, 2021 | 16.90 |
| Jun 30, 2021 | -0.74 |
| Mar 31, 2021 | -7.79 |